Serum M2-pyruvate kinase: A promising non-invasive biomarker for colorectal cancer mass screening

doi:10.4251/wjgo.v4.i6.145

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4660)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

425

HTML

3659

Figures (1-1)

292

Tables (1-4)

284

Sum=4660

Jun 15, 2012 (publication date) through Jan 23, 2025

Times Cited of This Article

Times Cited (23)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastrointest Oncol. Jun 15, 2012; 4(6): 145-151
Published online Jun 15, 2012. doi: 10.4251/wjgo.v4.i6.145

Full Size Figure Download Figure

Figure 1 Comparison of diagnostic values between serum M2-pyruvate kinase and carcinoembryonic antigen for positive colorectal lesions based on sensitivity and specificity in Hangzhou, 2006-2008. M2-PK: M2-pyruvate kinase; CEA: Carcinoembryonic antigen; CRC: Colorectal cancer; Adv.: Advanced; Nonad.: Nonadenomatous; Sens: Sensitivity; Spec: Specificity.

Citation: Meng W, Zhu HH, Xu ZF, Cai SR, Dong Q, Pan QR, Zheng S, Zhang SZ. Serum M2-pyruvate kinase: A promising non-invasive biomarker for colorectal cancer mass screening. World J Gastrointest Oncol 2012; 4(6): 145-151
URL: https://www.wjgnet.com/1948-5204/full/v4/i6/145.htm
DOI: https://dx.doi.org/10.4251/wjgo.v4.i6.145